Monitor for additional insider selling in the next quarter; while this cluster is small in dollar terms, coordinated C-suite selling could signal reduced conviction if it continues. No immediate trading action warranted.
QTTB drugs
QTTB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 25 $4.73entry
- T+1 · 9mo ago +0.63%α +1.18% · $4.76
- T+5 · 9mo ago 0.00%α +1.10% · $4.73
- T+20 · 8mo ago +53.28%α +58.51% · $7.25
- T+60 · 6mo ago +19.87%α +12.92% · $5.67
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three executive insiders at Q32 Bio Inc. (QTTB) sold shares in a coordinated open-market transaction on February 25, 2026, totaling approximately $75,418 in value. The sellers include the CEO, CFO and President, and Chief Scientific Officer, indicating broad-based insider selling at the C-suite level. Given the small total value relative to the company's $59M market cap, this is consistent with routine portfolio management rather than a material negative signal.
Key Financial Metrics
Key Facts
- CEO Jodie Pope Morrison sold 9,896 shares for $44,675
- CFO and President Lee Kalowski sold 3,995 shares for $18,035
- CSO Violette Shelia M. sold 2,815 shares for $12,708
- All sales occurred on the same day at $4.5144 per share
- Total proceeds: $75,418 across three C-suite executives
Financial Impact
$75,418 in total insider sales, representing 0.13% of the $59M market cap
Risk Factors
- Perception of lack of confidence if selling continues
- Limited float sensitivity due to small market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-QTTB-1772236841201 |
Track record
23 reports on QTTB
3 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +48.47% at T+60 after the Jul 14, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $8.29 Now $8.29 −0.00% settles Dec 16
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.47 Now $8.29 −2.13% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $8.71 Now $8.29 −4.82% settles Dec 15
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $9.34 Now $8.29 −11.24% settles Dec 8
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $9.34 Now $8.29 −11.24% settles Dec 8
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $8.97 Now $8.29 −7.58% settles Dec 3
- Oct 28, 202619d ago SC 13G Neutral 4/10 Entry $9.06 Now $8.29 −8.50% settles Nov 25
- Oct 9, 20265w ago SC 13G Neutral 4/10 Entry $8.74 to $9.36 Now $8.29 −5.15% ▲ +7.09% +10.36% vs SPY
- Sep 30, 20266w ago 8-K Bullish 6/10 Entry $8.27 to $8.71 Now $8.29 +0.24% ▲ +5.32% +4.05% vs SPY
- Sep 14, 20269w ago 8-K Neutral 3/10 Entry $10.91 to $8.74 Now $8.29 −24.01% ▼ −19.89% −22.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers